Capital Performance Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
6,920
+216
+3% +$35.1K 0.07% 122
2025
Q4
$1.31M Buy
6,704
+2,502
+60% +$596K 0.09% 96
2025
Q3
$1.18M Buy
4,202
+542
+15% +$138K 0.19% 64
2025
Q2
$800K Sell
3,660
-147
-4% -$23.7K 0.16% 73
2025
Q1
$532K Buy
3,807
+1,502
+65% +$245K 0.12% 96
2024
Q4
$384K Sell
2,305
-368
-14% -$65.4K 0.12% 73
2024
Q3
$455K Buy
2,673
+1,208
+82% +$175K 0.14% 53
2024
Q2
$207K Buy
+1,465
New +$182K 0.08% 85

Other funds holding ORCL

Capital Performance Advisors's ORCL Position: Q1 2026 in Review

Capital Performance Advisors increased its Oracle (ORCL) stake by 3.2% in Q1 2026, buying an estimated $35.1K and bringing the position to 6,920 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #122.

Capital Performance Advisors first reported a position in ORCL in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.31M in Q4 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Capital Performance Advisors held 6,920 shares of Oracle worth $1.02M as of Q1 2026.
  • Capital Performance Advisors bought 216 Oracle shares in Q1 2026, an estimated $35.1K.
  • Oracle made up 0.07% of Capital Performance Advisors's portfolio in Q1 2026, its #122 holding.
  • Capital Performance Advisors first reported a position in Oracle in Q2 2024 and has held it in 8 quarters since.
  • Capital Performance Advisors's Oracle position peaked at $1.31M in Q4 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Capital Performance Advisors's 13F filing for Q1 2026, filed 7 May 2026.